InvestorsHub Logo
Followers 1
Posts 47
Boards Moderated 0
Alias Born 08/02/2017

Re: None

Tuesday, 11/03/2020 12:26:23 PM

Tuesday, November 03, 2020 12:26:23 PM

Post# of 17421
The “bad pick” Ariad resulted in a seven figure profit for those of us who didn’t sell on the Ponatinib crash which was significntly worse than losing DES. The smart money is buying these cheap shares now in anticipation of good news fairly soon. The company can now focus its resources and cash on commercializing Voc and negotiating a good buyout without having to be concerned about having to raise additional funds as would have been necessary if the DES program moved forward. I look forward to another seven figure profit on this “bad pick” in the near future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News